Nonalcoholic steatohepatitis and noncirrhotic hepatocellular carcinoma: fertile soil
- PMID: 22418886
- DOI: 10.1055/s-0032-1306424
Nonalcoholic steatohepatitis and noncirrhotic hepatocellular carcinoma: fertile soil
Abstract
Nonalcoholic fatty liver disease (NAFLD) is easily the most common cause of chronic liver disease in the United States (U.S.) as the hepatic manifestation of the metabolic syndrome. Although only 5 to 20% of patients with NAFLD are generally considered to meet criteria for nonalcoholic steatohepatitis (NASH), with its inherent risk for progression to cirrhosis, this still represents an alarmingly large number of individuals. The exponentially growing rates of hepatocellular carcinoma (HCC) in the U.S. may be partially attributable to increased numbers of NASH cirrhotics, although recent evidence has suggested that NAFLD may directly promote hepatic carcinogenesis independent of cirrhosis. This review focuses on HCC in noncirrhotic NASH with an emphasis on clinical presentation, pathogenesis, and implications for screening.
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.
Similar articles
-
NAFLD leads to liver cancer: do we have sufficient evidence?Cancer Lett. 2014 Apr 10;345(2):230-4. doi: 10.1016/j.canlet.2013.07.033. Epub 2013 Aug 11. Cancer Lett. 2014. PMID: 23941829 Review.
-
Iron overload in nonalcoholic steatohepatitis.Adv Clin Chem. 2011;55:105-32. doi: 10.1016/b978-0-12-387042-1.00006-x. Adv Clin Chem. 2011. PMID: 22126026 Review.
-
Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma.Clin Liver Dis. 2018 Feb;22(1):201-211. doi: 10.1016/j.cld.2017.08.014. Clin Liver Dis. 2018. PMID: 29128057 Review.
-
Molecular Pathogenesis of Nonalcoholic Steatohepatitis- (NASH-) Related Hepatocellular Carcinoma.Can J Gastroenterol Hepatol. 2018 Aug 29;2018:8543763. doi: 10.1155/2018/8543763. eCollection 2018. Can J Gastroenterol Hepatol. 2018. PMID: 30228976 Free PMC article. Review.
-
Nonalcoholic fatty liver disease and hepatocellular carcinoma.Metabolism. 2016 Aug;65(8):1151-60. doi: 10.1016/j.metabol.2016.01.010. Epub 2016 Jan 23. Metabolism. 2016. PMID: 26907206 Review.
Cited by
-
Oncostatin M is overexpressed in NASH-related hepatocellular carcinoma and promotes cancer cell invasiveness and angiogenesis.J Pathol. 2022 May;257(1):82-95. doi: 10.1002/path.5871. Epub 2022 Mar 7. J Pathol. 2022. PMID: 35064579 Free PMC article.
-
Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: An increasing concern.Indian J Med Res. 2019 Jan;149(1):9-17. doi: 10.4103/ijmr.IJMR_1456_17. Indian J Med Res. 2019. PMID: 31115369 Free PMC article. Review.
-
Primary hepatocellular carcinoma and metabolic syndrome: An update.World J Gastrointest Oncol. 2013 Sep 15;5(9):186-94. doi: 10.4251/wjgo.v5.i9.186. World J Gastrointest Oncol. 2013. PMID: 24069511 Free PMC article. Review.
-
Circulating AIM as an indicator of liver damage and hepatocellular carcinoma in humans.PLoS One. 2014 Oct 10;9(10):e109123. doi: 10.1371/journal.pone.0109123. eCollection 2014. PLoS One. 2014. PMID: 25302503 Free PMC article.
-
Hepatocellular Carcinoma Presenting as Dyspnea at Rest due to Innumerable Lung Metastasis.J Clin Exp Hepatol. 2016 Dec;6(4):319-320. doi: 10.1016/j.jceh.2016.05.005. Epub 2016 May 24. J Clin Exp Hepatol. 2016. PMID: 28003722 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials